Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MEN1 | O00255 | 1/20 | 0.62 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.62 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.62 |
| ▸ | LMNA | P02545 | 4/20 | 0.54 |
| ▸ | HTT | P42858 | 3/20 | 0.54 |
| ▸ | HPGD | P15428 | 3/20 | 0.54 |
| ▸ | MAPT | P10636 | 2/20 | 0.54 |
| ▸ | TSHR | P16473 | 2/20 | 0.54 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.54 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.54 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.54 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.54 |
| ▸ | POLB | P06746 | 2/20 | 0.50 |
| ▸ | TP53 | P04637 | 1/20 | 0.50 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.50 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.50 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.50 |
| ▸ | DAO | P14920 | 1/20 | 0.49 |
| ▸ | HTR7 | P34969 | 3/20 | 0.47 |
| ▸ | IDO1 | P14902 | 1/20 | 0.47 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL14198908 | 0.84 | CYP1A2 (0.64) | MEN1CYP1A2KMT2ALMNAHTT | |
| SCHEMBL30530480 | 0.83 | GRIA1 (0.52) | MEN1CYP1A2KMT2ALMNAHTT | |
| SCHEMBL11049972 | 0.80 | CYP1A2 (0.68) | MEN1CYP1A2KMT2ALMNAHTT | |
| SCHEMBL10902799 | 0.80 | MEN1 (0.58) | MEN1CYP1A2KMT2ALMNAHTT | |
| SCHEMBL11768010 | 0.80 | MEN1 (0.58) | MEN1CYP1A2KMT2ALMNAHTT | |
| SCHEMBL1260406 | 0.80 | CYP1A2 (0.64) | MEN1CYP1A2KMT2AHPGDTSHR | |
| SCHEMBL5777717 | 0.79 | MEN1 (0.57) | MEN1CYP1A2KMT2ALMNAHTT | |
| SCHEMBL5777721 | 0.79 | MEN1 (0.57) | MEN1CYP1A2KMT2ALMNAHTT | |
| SCHEMBL30930111 | 0.79 | CYP1A2 (0.61) | MEN1CYP1A2KMT2ALMNAHTT | |
| SCHEMBL5779204 | 0.79 | MEN1 (0.57) | MEN1CYP1A2KMT2ALMNAHTT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1239 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-118852851-B | Preparation method of basalt fiber composite photovoltaic bracket material | 四川中辉创达新材料科技有限公司 | 2025-03-25 | — | — | CN | claimed |
| CN-118876310-A | Preparation process of etched PTFE multi-cavity microcatheter | 仙居翊科新材料科技有限公司 | 2024-11-01 | — | — | CN | claimed |
| CN-118852851-A | Preparation method of basalt fiber composite photovoltaic bracket material | 四川中辉创达新材料科技有限公司 | 2024-10-29 | — | — | CN | claimed |
| EP-1435957-B1 | INHIBITORS OF GSK-3 AND CRYSTAL STRUCTURES OF GSK-3BETA PROTEIN AND PROTEIN COMPLEXES | VERTEX PHARMA (US) | 2009-06-17 | — | — | EP | claimed |
| CN-1060837-A | BENZIMIDAZOLINONE DERIVATIVES | YAMANOUCHI PHARMA CO LTD (JP) | 1992-05-06 | — | — | CN | claimed |
| CN-118852851-B | Preparation method of basalt fiber composite photovoltaic bracket material | 四川中辉创达新材料科技有限公司 | 2025-03-25 | — | — | CN | disclosed |
| CN-118876310-A | Preparation process of etched PTFE multi-cavity microcatheter | 仙居翊科新材料科技有限公司 | 2024-11-01 | — | — | CN | disclosed |
| CN-118852851-A | Preparation method of basalt fiber composite photovoltaic bracket material | 四川中辉创达新材料科技有限公司 | 2024-10-29 | — | — | CN | disclosed |
| US-12031150-B2 | Methods, compositions and kits for increasing genome editing efficiency | VERTEX PHARMACEUTICALS INCORPORATED (US) | 2024-07-09 | — | — | US | disclosed |
| US-12024525-B2 | Benzodiazepine derivatives, compositions, and methods for treating cognitive impairment | AGENEBIO, INC. (US) | 2024-07-02 | — | — | US | disclosed |
| US-12005127-B2 | DNA-PK inhibitors | VERTEX PHARMACEUTICALS INCORPORATED (US) | 2024-06-11 | — | — | US | disclosed |
| CN-118103351-A | Coronavirus inhibitors | 共晶制药公司 | 2024-05-28 | — | — | CN | disclosed |
| US-5162318-A | Which have pulmonary surfactant secretion promoting activity | YAMANOUCHI PHARMACEUTICAL CO., LTD. (JP) | 1992-11-10 | — | — | US | disclosed |
| EP-0454330-A1 | Benzimidazolinone derivatives | YAMANOUCHI PHARMACEUTICAL CO. LTD. (JP) | 1991-10-30 | — | — | EP | disclosed |
| US-4175129-A | Antiemetic 1-(benzoxazolylalkyl)-piperidine derivatives | JANSSEN PHARMACEUTICA N.V. (BE) | 1979-11-20 | — | — | US | disclosed |
| US-4160836-A | Antiemetic 1-(benzothiazolylalkyl)piperidine derivatives | JANSSEN PHARMACEUTICA N.V. (BE) | 1979-07-10 | — | — | US | disclosed |
| US-4126688-A | ANTIEMETIC 1-(BENZOTRIAZOLYL-ALKYL)-PIPERIDINE DERIVATIVES | JANSSEN PHARMACEUTICA N.V. (BE) | 1978-11-21 | — | — | US | disclosed |
| US-4126687-A | ANTIEMETIC, 1-(BENZIMIDAZOLYL-ALKYL)-PIPERIDINE DERIVATIVES | JANSSEN PHARMACEUTICA N.V. (BE) | 1978-11-21 | — | — | US | disclosed |
| US-4110333-A | ANTIEMETIC INTERMEDIATES | JANSSEN PHARMACEUTICA N.V. (BE) | 1978-08-29 | — | — | US | disclosed |
| US-4066772-A | ANTIEMETICS | JANSSEN PHARMACEUTICA N.V. (BE) | 1978-01-03 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12031150-B2 | Methods, compositions and kits for increasing genome editing efficiency | DCLRE1B, XRCC6, MRE11 | MEN1 4181/4885CYP1A2 4336/4885KMT2A 1135/4885 |
| US-12024525-B2 | Benzodiazepine derivatives, compositions, and methods for treating cognitive impairment | GRM5, GABRA5, GABRE | MEN1 4661/4885CYP1A2 2206/4885KMT2A 2223/4885 |
| US-12005127-B2 | DNA-PK inhibitors | POLK, DTYMK, DCK | MEN1 3090/4885CYP1A2 2315/4885KMT2A 1065/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.